$AX

Axos Financial, Inc.

1
0
0

No SEC Form 4 filings for $AX in the last 30 days.

Med

Stock Picks: Sell Okta and Petco, Buy Axos Financial | Analyst Ratings May 2026 - News and Statistics

Wall Street analysts, according to a StockStory report, have flagged Okta and Petco as potential sells while recommending Axos Financial as a buy. Okta's subpar billings growth, slowing sales, and shrinking free cash flow margin raise concerns. Petco faces challenges with poor same-store sales and a high net-debt-to-EBITDA ratio, potentially leading to dilutive equity offerings, while Axos Financial is seen as a strong buy due to robust fundamentals and a positive outlook.

Axos (AX) Q3 2026 Earnings Call Transcript

Axos Financial reported strong Q3 2026 results with double-digit year-over-year growth in net interest income, earnings per share, and loan/deposit balances, driven by significant loan origination and strategic deposit acquisitions. The company detailed two major deposit acquisitions, including $2.3 billion from Genius Bank and a pending $3.2 billion from Capital One, aiming to enhance liquidity and support future loan growth. Despite a slight decline in net interest margin and a notable C&I loan charge-off, management expressed confidence in credit quality, operational efficiency initiatives, and continued loan growth in the low to mid-teens.

Raymond James Upgrades Axos Financial to Strong Buy Status

Raymond James has upgraded Axos Financial (AX) to a Strong Buy rating with a $100 price target, citing sustained confidence in the company's long-term organic growth and premium profitability. This upgrade follows Axos Bank's recognition by S&P Global as a top-performing publicly traded U.S. bank for 2025 among institutions with over $10 billion in assets. The company continues to be recognized as one of the fastest-growing financial stocks, driven by its digital-first approach and diverse financial services.